Skip to content
Longevity

Glutathione

γ-L-glutamyl-L-cysteinylglycine, an endogenous tripeptide antioxidant

Antioxidant research focused on redox balance, oxidative stress, and cellular detoxification pathways.

Limited Human Evidence

Route

Oral, IV and other routes exist clinically/research-wise

Common format

1,500 mg vial

Research focus

oxidative stress

Evidence level

Limited Human Evidence

Typical cycle

4–8 weeks

Longevity research motifLongevity

Glutathione in 30 seconds

Atlas Fast Read

What it is

γ-L-glutamyl-L-cysteinylglycine, an endogenous tripeptide antioxidant

Why people care

Antioxidant research focused on redox balance, oxidative stress, and cellular detoxification pathways.

Human evidence

Limited Human Evidence — Human interventional or clinical data exist, but studies are small, early-phase, mixed, indirect, route-specific, or not confirmatory.

Biggest misconception

Key gaps include larger independent trials, clearer dose-response data, long-term safety, clinically meaningful endpoints, and evidence that findings generalize beyond the narrow populations or routes already studied.

Bottom line

Glutathione has a real human signal or documented human pharmacology, but evidence is too small, mixed, route-specific, or indication-specific to justify broad claims.

Overview

What is Glutathione?

Glutathione is γ-L-glutamyl-L-cysteinylglycine, an endogenous tripeptide antioxidant. Antioxidant research focused on redox balance, oxidative stress, and cellular detoxification pathways.

Glutathione was identified as a biological sulfur-containing compound in the early 20th century and later established as a central intracellular antioxidant. Injectable use predates modern peptide-hacking culture and spans medical and wellness settings.

Mechanism

How it works

Acts as a major intracellular redox buffer and substrate for glutathione peroxidases, helping reduce peroxides and maintain protein thiol status. It also participates in xenobiotic conjugation through glutathione-S-transferases.

Research areas

oxidative stressredox biologydrug/toxin conjugationimmune function

Evidence

What does the evidence actually say?

Limited Human Evidence

Human interventional or clinical data exist, but studies are small, early-phase, mixed, indirect, route-specific, or not confirmatory.

01

Preclinical Evidence

02

Limited Human Evidence

03

Strong Human Evidence

Human evidence

Glutathione has extensive human biological relevance and has been studied by oral, IV, inhaled, and other routes for specific conditions. Evidence for routine injectable use to improve longevity, detoxification, or general performance is limited and highly indication-dependent.

Preclinical evidence

Extensive preclinical work establishes glutathione as a central antioxidant and detoxification system. The biology is not in question; the uncertainty is whether exogenous administration by a particular route produces the desired clinical outcome.

Knowledge gaps

Key gaps include larger independent trials, clearer dose-response data, long-term safety, clinically meaningful endpoints, and evidence that findings generalize beyond the narrow populations or routes already studied.

Protocol

Research protocol

DoseFrequencyTimingCycle

Dose

community sources SC reference: 100–200 mg/day. Medical IV protocols, when used, are different and indication-specific; oral/liposomal products also have different pharmacokinetics.

Frequency

Daily or every other day in the community SC protocol; some maintenance approaches use less frequent dosing.

Timing

No established time-of-day requirement.

Route

Oral, IV and other routes exist clinically/research-wise; Community sources list subcutaneous use. Route-specific evidence differs.

Cycle length

4–8 weeks

Reconstitution

Community reference: 3 mL bacteriostatic water per 1,500 mg vial = 500 mg/mL.

Storage

Community reference: lyophilized frozen; reconstituted 2–8 °C and protect from light; avoid repeated freeze-thaw.

Monitoring

CMP/renal function and clinical indication are more important than measuring glutathione levels routinely. Watch for hypersensitivity, respiratory symptoms and injection reactions.

Protocols vary widely between sources. Investigational compounds are not approved therapies, and approved products should follow their official labeling. Nothing here is medical advice.

Safety

Safety, side effects, and precautions

Side effects

Route-dependent adverse effects can include nausea, abdominal symptoms, headache, rash, bronchospasm/hypersensitivity and injection reactions. IV products carry additional sterility/infusion risks.

Contraindications

Avoid with known hypersensitivity. Asthma/bronchospasm history, pregnancy/breastfeeding, significant organ disease and concurrent cancer therapy warrant clinical review because evidence is indication- and route-specific.

Interactions

Interaction evidence is limited. Anticancer therapies that rely on oxidative stress are a theoretical/clinical concern; antioxidant use during chemotherapy or radiation should be coordinated with oncology.

Stacks

Common stacks

Glutathione + NAD+

Common wellness-clinic pairing intended to combine redox support with NAD metabolism.

No strong evidence that the combination improves longevity or performance.

Questions

FAQ

References

Sources

Atlas

The Atlas verdict

Glutathione has a real human signal or documented human pharmacology, but evidence is too small, mixed, route-specific, or indication-specific to justify broad claims. The most defensible use of the literature is to separate what has actually been measured in people from what is still extrapolated from mechanism or animal work.

More in Longevity